Radiation therapy has evolved into an integral modality in the treatment of non-small cell lung cancer ( NSCLC ) and small cell lung cancer ( SCLC ). As technology has evolved, stereotactic body radiotherapy ( SBRT ) can now be used to achieve excellent local control in patients with early ...
Advancements in radiotherapy for lung cancer in China Lung cancer is the leading cause of death due to cancer in China. In recent years, great progress has been made in radiotherapy for lung cancer patients in... L Zhao,L Wang - 《肿瘤学与转化医学(英文)》 被引量: 10发表: 2015年 Evalua...
commented: "This study confirms that we should take the dose to organs at risk into consideration, not only for malignant lymphoma and breast cancer patients, who are in general younger and have a much longer life expectancy, but also for lung cancer patients when cure is an option. The com...
Radiotherapy in Non-Small-Cell Lung Cancer 来自 dare.ubn.kun.nl 喜欢 0 阅读量: 11 作者: GWPM Kramer 摘要: Non-small-cell lung cancer (NSCLC) is a prominent cause of cancer death in many Western countries. 1 Of the 8000 new cases of lung cancer diagnosed yearly in the Netherlands,...
Clinical applications of noncoding RNAs in lung cancer patients SantoshKumar, ...AjayKumar, inClinical Applications of Noncoding RNAs in Cancer, 2022 5.11.2NcRNAs and their role in radioresistance Radiotherapy is considered among one of the most effective therapeutic strategies for various cancers, in...
Image-guided Radiotherapy of Lung Cancer 2025 pdf epub mobi 电子书 图书描述 Lung cancer is the leading cause of cancer death in the United States, but IGRT (image guided radiation therapy) offers the possibility of more aggressive and enhanced treatments. The only available source on the subject...
Lung cancer is the most common cancer in the world, with 2.2 million new cases and around 1.8 million deaths in 2020 alone. Although knowledge about the disease has improved considerably, and new therapeutic strategies can prolong the lives of previously
Advances in cancer immunotherapy have led to clinical trials of immunotherapy-based neoadjuvant treatments for early stage non-small-cell lung cancer. Evidence for priming of the immune system using both preoperative short-course radiotherapy and immunotherapy in this setting has now emerged from a rand...
Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial. Objectives: The non-small cell lung cancer (NSCLC) meta-analysis suggested a survival benefit for cisplatin-based chemotherapy when given in addition to su... Waller,D.,Peake,... - European...
None - 《Lung Cancer》 被引量: 216发表: 1991年 Radiotherapy alone in technically operable, medically inoperable, early-stage (I/II) non-small-cell lung cancer. B, Classen J, and Bamberg M (2002) Radiotherapy alone in technically operable, medically inoperable, early-stage (I/II) non-small...